Completed
GSK706769 Repeat Dose Study
NCT00711386
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Madison, Wisconsin, United States